Purchase Order 75D30124P20097

Award Date 9/17/24
Potential Completion Date 3/30/25
Potential Value $244K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
5
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
This is a $749,000.00 firm fixed price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to In Diagnostics, Inc. to develop endpoint and kinetic measurement capabilities on a low-cost, disposable spectrophotometer platform. The contract does not have a set-aside designation and is scheduled for completion by June 30, 2025. The awardee, In Diagnostics, Inc., is a for-profit organization located in Carlsbad, California.
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Inbios International, Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The $61,575 contract is for the provision of Inbios' DETECT IgM Capture ELISA Kit and accessories, which are used for infectious disease diagnostics. The award does not have a set-aside designation. Inbios has received multiple previous federal contract and grant awards from the...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to XCR Diagnostics, Inc., a manufacturer of goods focused on molecular diagnostics testing. The $147,000.00 contract is for the delivery of CBOT singleplex assays, laboratory supplies, and reagents to support the CDC's diagnostic testing capabilities in Pittsburgh, Pennsylvania and Atlanta, Georgia. The contract has a completion date of August 1, 2019...
This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type. The contract is for the development of an "easy-to-use, low-cost triplex RDT for the...
This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $174,160.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostic testing products, for the provision of CBOT singleplex assays and related laboratory supplies. This contract does not have a set-aside designation. XCR Diagnostics, Inc. is a subsidiary of Fluoresentric, Inc., another manufacturer of goods. The contract, awarded out of the CDC's...
This SBIR Phase I contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Immport Therapeutics, Inc., doing business as Antigen Discovery Inc. The $150,000.00 firm fixed price purchase order is for the company's high throughput protein microarray technology and related services. Immport Therapeutics has provided these products and services to support the CDC's detection and response efforts for pathogens such as monkeypox virus, Brucella,...
This is a $249,000 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Diasorin Inc., a foreign-owned for-profit company, for its "SCIENCE TEAM" requirement. The contract has an ultimate completion date of September 28, 2024. Diasorin Inc. is a manufacturer of fully automated diagnostic testing equipment, assays, reagents, and related services for the medical industry. It has a proven track record as a federal contractor,...

This $243,500 firm-fixed-price purchase order was awarded to Instadiagnostics Inc., a minority-owned, for-profit small business, by the Centers for Disease Control and Prevention (CDC) under the Small Business Innovation Research (SBIR) program. The contract is for the development of rapid diagnostic tests and devices related to SBIR Topic 37. Instadiagnostics Inc. has previously received federal grants from the CDC, Department of Defense, and National Institutes of Health for the development of innovative diagnostic solutions targeting infectious diseases such as viral hepatitis, sepsis, and organ dysfunction. This contract award is set aside for small businesses and has a period of performance ending on March 30, 2025.

Generated 9/18/24, 10:02 AM